Yu Zhu - Search Results

Year	Number of Results
1986	1
2002	13
2003	13
2004	15
2005	22
2006	19
2007	17
2008	37
2009	27
2010	40
2011	48
2012	66
2013	74
2014	88
2015	94
2016	97
2017	119
2018	135
2019	132
2020	173
2021	181
2022	227
2023	233
2024	272
2025	287
2026	214
2027	2

1

Treatment Sequencing in Platinum-Resistant Epithelial Ovarian Cancer After MIRASOL, KEYNOTE-B96, and ROSELLA.

Liu Y, Xu M, Ma J, Zhu Y, Gao M. Liu Y, et al. Among authors: zhu y. Int J Womens Health. 2026 Jul 10;18:624084. doi: 10.2147/IJWH.S624084. eCollection 2026. Int J Womens Health. 2026. PMID: 42453787 Free PMC article. Review.

2

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study.

Labeau SO, Afonso E, Benbenishty J, Blackwood B, Boulanger C, Brett SJ, Calvino-Gunther S, Chaboyer W, Coyer F, Deschepper M, François G, Honore PM, Jankovic R, Khanna AK, Llaurado-Serra M, Lin F, Rose L, Rubulotta F, Saager L, Williams G, Blot SI; DecubICUs Study Team; European Society of Intensive Care Medicine (ESICM) Trials Group Collaborators. Labeau SO, et al. Intensive Care Med. 2021 Feb;47(2):160-169. doi: 10.1007/s00134-020-06234-9. Epub 2020 Oct 9. Intensive Care Med. 2021. PMID: 33034686 Free PMC article.

3

Aberrant phase separation drives membranous organelle remodeling and tumorigenesis.

Wang X, Jiang A, Meng Q, Jiang T, Lu H, Geng X, Song Z, Hu X, Yu Z, Xu W, Ning C, Lin Y, Li D. Wang X, et al. Among authors: yu z. Mol Cell. 2025 May 1;85(9):1852-1867.e10. doi: 10.1016/j.molcel.2025.04.001. Epub 2025 Apr 23. Mol Cell. 2025. PMID: 40273917

4

IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial.

Zhang H, Sun J, Li Y, Zhu L, Shan Z, Lu W, Shen J, Shi Y, Tao L, Jiang H, Ji L, Zhu Y, Gu H, Liu X, Sun B, Tian Y, Liu Q, Zhou J, Zhao H, Guan H, Zhu L, Wen J, Lu Y, Qiao J, Zhang W, Deng J, Lu S, Han-Zhang H, Qian L, Zhou H, Fan X. Zhang H, et al. Among authors: zhu y. JAMA Ophthalmol. 2025 Nov 1;143(11):964-971. doi: 10.1001/jamaophthalmol.2025.3350. JAMA Ophthalmol. 2025. PMID: 41066129 Clinical Trial.

5

A central CeA-LC-PVH circuit mediates stress-induced osteopenia via skeletal sympathetic nerves in male mice.

Zhao WJ, Lu YX, Fan GD, Zhou J, Tan CY, Huang PP, Ye B, Xie F, Zhu Y, Wang BH, Liu CH, Dou XY, Dong YL, Hu XY. Zhao WJ, et al. Among authors: zhu y. Sci Adv. 2025 Dec 5;11(49):eadz9329. doi: 10.1126/sciadv.adz9329. Epub 2025 Dec 5. Sci Adv. 2025. PMID: 41348891 Free PMC article.

6

Leveraging intratumoral probiotics for pancreatic cancer immunotherapy via xenophagy.

Li B, Liu G, Zhu Y, Chen L, Zhang N, Zhu X, Sun Y, Liu X, Liu W, Ma Y, Tian X, Yang Y, Zhu M. Li B, et al. Among authors: zhu y. Cell Host Microbe. 2026 Apr 8;34(4):657-671.e7. doi: 10.1016/j.chom.2026.02.010. Epub 2026 Mar 6. Cell Host Microbe. 2026. PMID: 41794037

7

MoCA and MMSE for the detection of post-stroke cognitive impairment: a comparative diagnostic test accuracy systematic review and meta‑analysis.

Wei X, Liu Y, Li J, Zhu Y, Li W, Zhu Y, Hua L, Cao J, Ma Y. Wei X, et al. Among authors: zhu y. J Neurol. 2025 May 18;272(6):407. doi: 10.1007/s00415-025-13146-5. J Neurol. 2025. PMID: 40383729

8

CD103⁺CD8⁺ tissue-resident memory T lymphocytes of melanoma boost anti-tumour immunity and predict immunotherapy outcomes.

Zhang T, Song J, Li Y, Shen K, Xuan J, Gao Y, Lu L, Pang Z, Wang L, Yang Y, Gao Z, Hu Q, Zhu Y, Wei C, Zheng S, Luo R, Hou Y, Zhou Y, Wei C, Gu J. Zhang T, et al. Among authors: zhu y. Clin Transl Med. 2025 Sep;15(9):e70464. doi: 10.1002/ctm2.70464. Clin Transl Med. 2025. PMID: 40985995 Free PMC article.

9

The CLIC1-PKM2 axis orchestrates glycolytic metabolism to accelerate gastric cancer progression.

Yang J, Yu Z, Feng Y, Wang S, Li C, Mao Y, Xu W, Chen J. Yang J, et al. Among authors: yu z. J Transl Med. 2025 Nov 22;24(1):1. doi: 10.1186/s12967-025-07463-6. J Transl Med. 2025. PMID: 41275297 Free PMC article.

10

OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression.

Liu L, Zheng X, Zhao X, Mao X, Zhang F, Jiang Z, Gao Z, Wang Q, Zhu Y, Huang Y, Wang N, Li S, Zhang Y. Liu L, et al. Among authors: zhu y. Drug Resist Updat. 2026 Aug 9;89:101469. doi: 10.1016/j.drup.2026.101469. Online ahead of print. Drug Resist Updat. 2026. PMID: 42600365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,354 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,354 results

Results by year